Mesoblast (MEOBF) Invested Capital (2015 - 2026)

Mesoblast has disclosed Invested Capital across 10 years of filings, most recently posting $579.0 million for Q2 2026.

• In Q2 2026, Invested Capital fell 11.14% year-over-year to $579.0 million; the TTM figure through Jun 2026 stood at $579.0 million (down 11.14% YoY), while the FY2026 annual figure was $579.0 million, down 11.14% from the prior year.
• Invested Capital came in at $579.0 million for Q2 2026 at Mesoblast, down from $641.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $651.6 million in Q2 2025 to a low of $478.8 million in Q4 2024.
• Average Invested Capital over 5 years is $534.9 million, with a median of $512.5 million recorded in 2023.
• Year-over-year, Invested Capital retreated 20.89% in 2022 and soared 33.97% in 2025.
• Over 5 years, Invested Capital stood at $505.9 million in 2022, then rose by 2.24% to $517.3 million in 2023, then fell by 7.44% to $478.8 million in 2024, then surged by 33.97% to $641.4 million in 2025, then dropped by 9.73% to $579.0 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $579.0 million in Q2 2026, $641.4 million in Q4 2025, and $651.6 million in Q2 2025.